Bicara Therapeutics (BCAX) EPS (Diluted) (2023 - 2026)
Powered by 
Analysis
Bicara Therapeutics (BCAX) EPS (Diluted) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 0.15 |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.06 |
| 10 | Bicara Therapeutics | 1.57 Bn | 1.57 Bn | - | -0.82 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.82 |
| Mar 31, 2026 | -0.93 |
| Dec 31, 2025 | -0.68 |
| Sep 30, 2025 | -0.67 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | -1.25 |
| Sep 30, 2024 | -1.60 |
| Jun 30, 2024 | -19.01 |
| Mar 31, 2024 | -18.94 |
| Dec 31, 2023 | -21.44 |
| Sep 30, 2023 | -38.23 |